5-PLASMA Bivalirudin Calibrator, Model Number 5D-46905
Published August 12, 2026 · Recall initiated: July 1, 2026
Summary
FDA records medical device Class II recall Z-2895-2026, published August 12, 2026 and initiated July 1, 2026. Recalling firm: Aniara Diagnostica LLC; Status: Ongoing; Reported quantity: 7 units; Lot: UDI-DI: 05070002420392, Lot Number: KE132601. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Aniara Diagnostica LLC
- Distributor
- US Nationwide distribution in the states of IL, NC, TN.
- Lot
- UDI-DI: 05070002420392, Lot Number: KE132601
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA5-PLASMA Bivalirudin AMR Verification Kit, Model Number 5D-45905August 12, 2026
- FDA5-PLASMA Bivalirudin Control, Model Number 5D-44905August 12, 2026
- FDAPhilips Allura, Cardio Vascular-Allura Centron. Model Number: 722400. Interventional Fluoroscopic X-RayAugust 12, 2026
- FDABrand Name: U2 Total Knee System Product Name: Femoral offset bushing, 0mm and 4mm Model/Catalog Number:August 12, 2026
- FDAPhilips Azurion under the following System Descriptions and corresponding model numbers: 1. Azurion 3 M12;August 12, 2026
- FDAZYMUTEST HIA IgG, in vitro diagnostic ELISA kit, Ref. RK040AMay 20, 2026
Questions about this recall
Was 5-PLASMA Bivalirudin Calibrator, Model Number 5D-46905 recalled?
Yes. FDA published recall Z-2895-2026 on August 12, 2026. Reported hazard: Stability issues with the reconstituted lyophilized human plasma and bivalirudin matrix have been identified. These stability issues lead to a degradation of measurable bivalirudin in the controls, calibrators, and linearity values.
What should I do if I have this product?
Voluntary: Firm initiated · Letter